Home Visiting for Child Development and Parenting
Trial Summary
What is the purpose of this trial?
This study involves a long-term outcome study of the Catholic Health Initiative St. Joseph's Children (CHI SJC) program using a randomized control study. The purpose of this study is to determine the short-term and long-term impact and effectiveness of the CHI SJC program. The CHI SJC program has not been studied to determine program effectiveness. The investigators intend to follow families and their children until the children in the study graduate from high-school or turn 19 years of age. The study, as a template, uses the eight outcome domains listed and described in the Home Visiting Evidence of Effectiveness website (http://homvee.acf.hhs.gov/outcomes.aspx). These eight domains are: * Child development and school readiness * Family economic self-sufficiency * Maternal health * Reductions in child maltreatment * Child health * Linkages and referrals * Positive parenting practices * Reductions in juvenile delinquency, family violence, and crime The investigators expect to observe significant differences among the two groups with respect to the primary outcome domains listed. The investigators expect study group members randomized to the CHI SJC program will perform better on the eight outcome domains. Other hypotheses include: Other Hypotheses: Hypothesis 1. Randomization to CHI SJC will be associated with higher quality functioning and better child health and well-being. Hypothesis 2. Randomization to CHI SJC will result in more connections to community resources. Hypothesis 3. Randomization to CHI SJC will result in improved indications of maternal health and positive parenting practices. Hypothesis 4. Randomization to CHI SJC will be associated with higher measures of family economic self-sufficiency. Hypothesis 5. Randomization to CHI SJC will be associated with increased school readiness and school progress and attainment. Hypothesis 6. Randomization to CHI SJC will be associated with reductions in juvenile delinquency, family violence, and crime. The study will collect outcome data in the same way and, at the same time, from treatment and control group members. Data collection will primarily be comprised of a set of self-report questionnaires and a review of administrative records that target the outcome domains described earlier. Study group members will be assessed at baseline, 6 months, 12 months, 18 months, 24 months, 3 years, 5 years, 8 years, 12 years, 15 years, and at high-school graduation or 19 years of age.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Home Visiting for child development and parenting?
Research shows that home visiting programs are effective in improving parent skills, child-caregiver relationships, and children's language development, especially when they start during pregnancy and last over a year. These programs are particularly beneficial for vulnerable families, helping to support early childhood development and caregiver mental health.12345
Is home visiting for child development and parenting safe?
How does the home visiting treatment for child development and parenting differ from other treatments?
Home visiting is unique because it involves professionals visiting families at home to provide parenting education, social support, and connections to community services, which can help improve child development and health outcomes. This approach is different from other treatments that might not offer the same level of personalized, in-home support and integration with community resources.6891011
Research Team
Paul Guerin, PhD
Principal Investigator
University of New Mexico
Eligibility Criteria
This trial is for families with a first-born child who is 3 months old or younger, living within the program's 3-county area. It aims to assess the impact of home visits on various aspects of child development and family well-being.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial data collection using self-report questionnaires and administrative records
Longitudinal Follow-up
Participants are monitored at multiple time points to assess outcomes across various domains
Data Analysis and Reporting
Analysis of collected data to evaluate the impact and effectiveness of the CHI SJC program
Treatment Details
Interventions
- Home Visiting
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor